We are live on ! Find out more
KB

Kimelman & Baird Portfolio holdings

AUM $1.22B
1-Year Est. Return 11.47%
This Fund
S&P 500
This Quarter Est. Return
+2.22%
1 Year Est. Return
+11.47%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$660M
AUM Growth
+$3.27M
Cap. Flow
-$5.55M
Cap. Flow %
-0.84%
Top 10 Hldgs %
37.72%
Holding
128
New
6
Increased
27
Reduced
22
Closed
7

Top Buys

Rank Stock Value
1
COST icon
Costco
COST
+$14.7M
2
XBI icon
State Street SPDR S&P Biotech ETF
XBI
+$5.15M
3
COP icon
ConocoPhillips
COP
+$4.54M
4
FTI icon
TechnipFMC
FTI
+$455K
5
MRK icon
Merck
MRK
+$354K

Top Sells

Rank Stock Value
1
CPRT icon
Copart
CPRT
+$16.6M
2
CMD
Cantel Medical Corporation
CMD
+$9.35M
3
LLY icon
Eli Lilly
LLY
+$2.25M
4
MJN
Mead Johnson Nutrition Company
MJN
+$1.34M
5
BMY icon
Bristol-Myers Squibb
BMY
+$490K

Sector Composition

Rank Sector Weight
1 Industrials 18.86%
2 Financials 14.21%
3 Healthcare 12.56%
4 Consumer Discretionary 12.5%
5 Communication Services 11.09%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
QEP
76
DELISTED
QEP RESOURCES, INC.
QEP
$542K 0.08%
53,670
+1,600
+3% +$17.3K
CERN
77
DELISTED
Cerner Corp
CERN
$518K 0.08%
7,800
– –
NFLX icon
78
Netflix
NFLX
$292B
$504K 0.08%
33,750
– –
AMT icon
79
American Tower
AMT
$77.7B
$498K 0.08%
3,763
– –
IDXX icon
80
Idexx Laboratories
IDXX
$42.9B
$484K 0.07%
3,000
-1,000
-25% -$162K
EOG icon
81
EOG Resources
EOG
$78B
$471K 0.07%
5,200
-1,500
-22% -$138K
LH icon
82
Labcorp
LH
$24.3B
$462K 0.07%
3,492
– –
KWR icon
83
Quaker Houghton
KWR
$2.63B
$436K 0.07%
3,000
– –
BABA icon
84
Alibaba
BABA
$269B
$423K 0.06%
3,000
– –
WMT icon
85
Walmart Inc
WMT
$871B
$416K 0.06%
16,500
– –
FTI icon
86
TechnipFMC
FTI
$30.6B
$408K 0.06%
+20,160
New +$455K
PHO icon
87
Invesco Water Resources ETF
PHO
$1.97B
$405K 0.06%
15,000
– –
D icon
88
Dominion Energy
D
$62.5B
$398K 0.06%
5,200
– –
ENB icon
89
Enbridge
ENB
$124B
$392K 0.06%
9,840
+4,920
+100% +$198K
MO icon
90
Altria Group
MO
$122B
$365K 0.06%
4,900
– –
CELG
91
DELISTED
Celgene Corp
CELG
$351K 0.05%
2,700
– –
KO icon
92
Coca-Cola
KO
$354B
$336K 0.05%
7,500
– –
ZBH icon
93
Zimmer Biomet
ZBH
$17.7B
$334K 0.05%
2,678
– –
MHG
94
DELISTED
Marine Harvest ASA
MHG
$299K 0.05%
17,500
– –
PM icon
95
Philip Morris
PM
$301B
$295K 0.04%
2,515
– –
LCNB icon
96
LCNB Corp
LCNB
$285M
$286K 0.04%
14,300
– –
VTR icon
97
Ventas
VTR
$48.9B
$273K 0.04%
3,933
– –
DE icon
98
Deere & Co
DE
$170B
$272K 0.04%
2,200
– –
TWX
99
DELISTED
Time Warner Inc
TWX
$268K 0.04%
2,666
– –
GCP
100
DELISTED
GCP Applied Technologies Inc.
GCP
$265K 0.04%
8,680
– –
1 2 3
4
5

Similar funds

DPI
Diversified Portfolios Inc Bloomfield Hills, Michigan $1.22B AUM 11.83% 1-Year Est. Return
NPIC
Neumeier Poma Investment Counsel Carmel, California $1.21B AUM 70.48% 1-Year Est. Return
CS
Central Securities New York $1.21B AUM 19.91% 1-Year Est. Return
AG
Atairos Group Bryn Mawr, Pennsylvania $1.22B AUM 38.2% 1-Year Est. Return
TIM
Tortoise Investment Management White Plains, New York $1.21B AUM 13.04% 1-Year Est. Return
CCM
Coliseum Capital Management Rowayton, Connecticut $1.22B AUM 18.72% 1-Year Est. Return
GC
Gillson Capital Chicago, Illinois $1.22B AUM 7.54% 1-Year Est. Return
LWIC
Leith Wheeler Investment Counsel Vancouver, British Columbia, Canada $1.21B AUM 12.04% 1-Year Est. Return

Kimelman & Baird's Q2 2017 Portfolio in Review

As of Q2 2017, Kimelman & Baird held 128 positions worth $660M, up 0.5% from $657M the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Kimelman & Baird's Q2 2017 filing shows 6 new, 27 increased, 22 reduced and 7 closed positions. Its largest new stake was State Street SPDR S&P Biotech ETF: 72,640 shares worth $5.61M. The largest sale was Copart, an estimated $16.6M.

By sector, the portfolio is most concentrated in Industrials at 19% of assets, down from 21% a quarter earlier, followed by Financials and Healthcare.

  • Kimelman & Baird's largest Q2 2017 buy was State Street SPDR S&P Biotech ETF: 72,640 shares worth $5.61M.
  • Kimelman & Baird added most to Costco in Q2 2017, an estimated $14.7M increase.
  • Kimelman & Baird's biggest Q2 2017 reduction was Copart, cutting an estimated $16.6M.
  • Kimelman & Baird fully exited Mead Johnson Nutrition Company in Q2 2017, selling an estimated $1.34M.
  • Kimelman & Baird's ten largest holdings make up 38% of its $660M portfolio in Q2 2017.
  • Kimelman & Baird opened 6 new positions and closed 7 in Q2 2017.
  • Kimelman & Baird's portfolio value rose 0.5% quarter-over-quarter to $660M.

Based on Kimelman & Baird's 13F filing for Q2 2017, filed 22 Aug 2017.